News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
34,360 Results
Type
Article (3965)
Company Profile (21)
Press Release (30374)
Multimedia
Podcasts (9)
Webinars (2)
Section
Business (7660)
Career Advice (630)
Deals (1547)
Drug Delivery (32)
Drug Development (4683)
Employer Resources (38)
FDA (840)
Job Trends (1379)
News (15087)
Policy (1631)
Tag
2027 Genetown Elite (1)
2027 Pharm Country Standard (1)
Academia (218)
Accelerated approval (7)
Adcomms (3)
Allergies (34)
Alliances (1796)
ALS (4)
Alzheimer's disease (93)
Antibody-drug conjugate (ADC) (29)
Approvals (873)
Artificial intelligence (49)
Autoimmune disease (11)
Automation (2)
Bankruptcy (14)
Best Places to Work (1121)
BIOSECURE Act (1)
Biosimilars (15)
Biotechnology (15)
Bladder cancer (17)
Brain cancer (2)
Breast cancer (41)
Cancer (478)
Cardiovascular disease (29)
Career advice (547)
Career pathing (16)
CAR-T (25)
CDC (6)
Cell therapy (65)
Cervical cancer (1)
Clinical research (3998)
Collaboration (91)
Compensation (11)
Complete response letters (1)
COVID-19 (223)
CRISPR (4)
C-suite (47)
Cystic fibrosis (5)
Data (523)
Decentralized trials (1)
Denatured (3)
Depression (25)
Diabetes (45)
Diagnostics (313)
Digital health (2)
Diversity (4)
Diversity, equity & inclusion (13)
Drug discovery (23)
Drug pricing (32)
Drug shortages (4)
Duchenne muscular dystrophy (21)
Earnings (3420)
Editorial (19)
Employer branding (8)
Employer resources (40)
Events (4431)
Executive appointments (31)
FDA (1115)
Friedreich's ataxia (2)
Funding (95)
Gene editing (13)
Generative AI (8)
Gene therapy (49)
GLP-1 (91)
Government (319)
Grass and pollen (1)
Guidances (39)
Healthcare (1167)
HIV (7)
Huntington's disease (9)
IgA nephropathy (4)
Immunology and inflammation (28)
Immuno-oncology (8)
Indications (14)
Infectious disease (257)
Inflammatory bowel disease (12)
Inflation Reduction Act (8)
Influenza (17)
Intellectual property (18)
Interviews (127)
IPO (839)
IRA (13)
Job creations (255)
Job search strategy (445)
JPM (20)
Kidney cancer (3)
Labor market (46)
Layoffs (58)
Leadership (17)
Legal (307)
Liver cancer (17)
Lung cancer (71)
Lymphoma (62)
Machine learning (5)
Management (13)
Manufacturing (62)
MASH (9)
Medical device (542)
Medtech (543)
Mergers & acquisitions (789)
Metabolic disorders (116)
Multiple sclerosis (15)
Neurodegenerative disease (23)
Neuropsychiatric disorders (7)
Neuroscience (195)
NextGen: Class of 2026 (497)
Non-profit (385)
Now hiring (25)
Obesity (61)
Opinion (67)
Ovarian cancer (10)
Pain (9)
Pancreatic cancer (22)
Parkinson's disease (13)
Partnered (22)
Patents (32)
Patient recruitment (27)
Peanut (9)
People (2122)
Pharmaceutical (8)
Pharmacy benefit managers (3)
Phase 1 (1132)
Phase 2 (1669)
Phase 3 (1595)
Pipeline (399)
Policy (59)
Postmarket research (100)
Preclinical (492)
Press Release (2)
Prostate cancer (47)
Psychedelics (5)
Radiopharmaceuticals (21)
Rare diseases (63)
Real estate (167)
Recruiting (17)
Regulatory (1415)
Reports (27)
Research institute (166)
Resumes & cover letters (87)
RNA editing (3)
RSV (13)
Schizophrenia (20)
Series A (13)
Series B (4)
Sickle cell disease (2)
Special edition (22)
Spinal muscular atrophy (10)
Sponsored (7)
Startups (174)
Stomach cancer (1)
Supply chain (13)
Tariffs (16)
The Weekly (6)
Vaccines (105)
Venture capital (17)
Weight loss (52)
Women's health (6)
Worklife (9)
Date
Last 7 days (30)
Last 30 days (122)
Last 365 days (2133)
2026 (160)
2025 (2283)
2024 (2529)
2023 (2176)
2022 (3168)
2021 (3389)
2020 (3051)
2019 (2895)
2018 (2072)
2017 (1640)
2016 (1738)
2015 (1736)
2014 (1108)
2013 (828)
2012 (887)
2011 (889)
2010 (715)
Location
Africa (171)
Alabama (2)
Arizona (12)
Arkansas (2)
Asia (2672)
Australia (476)
California (645)
Canada (178)
China (146)
Colorado (14)
Connecticut (72)
Delaware (44)
Europe (4908)
Florida (103)
Georgia (24)
Idaho (4)
Illinois (127)
India (5)
Indiana (55)
Iowa (1)
Japan (34)
Kansas (4)
Kentucky (5)
Maine (1)
Maryland (104)
Massachusetts (308)
Michigan (11)
Minnesota (29)
Mississippi (1)
Missouri (3)
Montana (3)
Nebraska (1)
Nevada (4)
New Jersey (242)
New Mexico (1)
New York (193)
North Carolina (65)
North Dakota (1)
Northern California (284)
Ohio (16)
Oregon (3)
Pennsylvania (140)
Puerto Rico (1)
Rhode Island (5)
South America (182)
Southern California (297)
Tennessee (10)
Texas (42)
United States (2258)
Utah (14)
Virginia (12)
Washington D.C. (11)
Washington State (60)
West Virginia (2)
Wisconsin (5)
34,360 Results for "ars".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
ARS Pharmaceuticals to Participate in Piper Sandler 37th Annual Healthcare Conference
November 27, 2025
·
1 min read
Press Releases
ARS Pharmaceuticals Announces Conference Call and Webcast for its Third Quarter 2025 Financial Results
November 4, 2025
·
1 min read
Approvals
ARS Wins FDA Approval for Neffy Spray for Children in Anaphylaxis
Neffy 1 mg is the “first significant innovation” for epinephrine delivery in small children aged 4 years and up in over 35 years, according to ARS Pharmaceuticals.
March 6, 2025
·
2 min read
·
Tristan Manalac
Press Releases
ARS Pharmaceuticals Reports Third Quarter 2025 Financial Results and Highlights for neffy® (epinephrine nasal spray)
November 10, 2025
·
17 min read
Press Releases
Moderna Secures $1.5 Billion Five-Year Credit Facility from Ares Management
November 21, 2025
·
4 min read
Press Releases
ARS Pharmaceuticals to Participate in Upcoming September 2025 Investor Conferences
August 29, 2025
·
1 min read
Press Releases
ARS Pharma Launches Get neffy® on Us for Patients with Severe Allergic Reactions to Improve Access to neffy (epinephrine nasal spray)
November 5, 2025
·
8 min read
Press Releases
JenaValve Announces New, Late-Breaking Results from the ALIGN-AR Trial Published in The Lancet and Presented at PCR London Valves
November 24, 2025
·
4 min read
Press Releases
ARS Pharmaceuticals Receives Favorable Decision from European Patent Office on Patent Related to neffy® (epinephrine nasal spray)
October 9, 2025
·
8 min read
Press Releases
Biogen Licenses Oral C5aR1 Antagonist from Vanqua Bio to Expand Immunology Portfolio
October 27, 2025
·
8 min read
1 of 3,436
Next
